Liederbach, Germany

Matthias Lohn


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
3 patents (USPTO):

Title: Matthias Lohn: Innovator in Isoquinoline Derivatives

Introduction

Matthias Lohn is a notable inventor based in Liederbach, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of isoquinoline derivatives. With a total of 3 patents, his work focuses on innovative solutions for treating diseases associated with Rho-kinase.

Latest Patents

Lohn's latest patents include groundbreaking inventions related to substituted isoquinoline and isoquinolinone derivatives. The first patent describes 6-substituted isoquinoline and isoquinoline derivatives that are useful for the treatment and/or prevention of diseases associated with Rho-kinase and/or Rho-kinase mediated phosphorylation of myosin light chain phosphatase. The second patent outlines a method for treating or preventing diseases in mammals by administering compounds of the formula (I) that target the same pathways.

Career Highlights

Matthias Lohn is currently employed at Sanofi, a global healthcare leader. His work at Sanofi has allowed him to focus on innovative research and development in the pharmaceutical industry. Lohn's expertise in isoquinoline derivatives has positioned him as a key player in the field of medicinal chemistry.

Collaborations

Throughout his career, Lohn has collaborated with esteemed colleagues such as Oliver Plettenburg and Armin Hofmeister. These collaborations have further enhanced his research and contributed to the advancement of his patented technologies.

Conclusion

Matthias Lohn's contributions to the field of medicinal chemistry through his patents on isoquinoline derivatives demonstrate his commitment to innovation and improving healthcare solutions. His work continues to have a significant impact on the treatment of diseases associated with Rho-kinase.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…